Loading...
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Na minha lista:
| Udgivet i: | Ann Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927326/ https://ncbi.nlm.nih.gov/pubmed/31407010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdz215 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|